Mouse model of sublethal and lethal intraperitoneal glanders (Burkholderia mallei)

被引:38
作者
Fritz, DL
Vogel, P
Brown, DR
Deshazer, D
Waag, DM
机构
[1] USA, Med Res Inst Infect Dis, Div Pathol, Ft Detrick, MD 21702 USA
[2] USA, Med Res Inst Infect Dis, Div Bacteriol, Ft Detrick, MD 21702 USA
关键词
Burkholderia mallei; capsular antigen; glanders; immunohistochemistry; intraperitoneal inoculation; mice; Mus;
D O I
10.1354/vp.37-6-626
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Sixty male BALB/c mice were inoculated intraperitoneally with either a sublethal or a lethal dose of Burkholderia mallei China 7 strain, then killed at multiple time points postinoculation. Histopathologic changes were qualitatively similar in both groups and consisted of pyogranulomatous inflammation. In sublethal study mice, changes were first seen at 6 hours in mediastinal lymph nodes, then in spleen, liver, peripheral lymph nodes, and bone marrow at day 3. These changes generally reached maximal incidence and severity by day 4 but decreased by comparison in all tissues except the liver. Changes were first seen in lethal study mice also at 6 hours in mediastinal lymph nodes and in spleens. At day 1, changes were present in liver, peripheral lymph nodes, and bone marrow. The incidence and severity of these changes were maximal at day 2. In contrast to sublethal study mice, the incidence and severity of the changes did not decrease through the remainder of the study. The most significant difference between the two groups was the rapid involvement of the spleen in the lethal study mice. Changes indicative of impaired vascular perfusion were more frequently seen in the sublethal study mice. Our findings indicate that mice are susceptible to B. mallei infection and may serve as an appropriate model for glanders infection in a resistant host such as human beings. Additionally, by immunoelectron microscopy, we showed the presence of type I O-antigenic polysaccharide (capsular) antigen surrounding B. mallei.
引用
收藏
页码:626 / 636
页数:11
相关论文
共 24 条
[1]  
ACHA PN, 1989, ZOONOSES COMMUNICABL, P86
[2]  
BENENSON AS, 1995, CONTROL COMMUNICABLE, P301
[3]   The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence [J].
DeShazer, D ;
Brett, PJ ;
Woods, DE .
MOLECULAR MICROBIOLOGY, 1998, 30 (05) :1081-1100
[4]   Bacterial persistence and expression of disease [J].
Domingue, GJ ;
Woody, HB .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (02) :320-+
[5]  
DUNGWORTH DL, 1993, PATHOLOGY DOMESTIC A, P553
[6]  
Dyadishchev N.R., 1997, ZH MIKROBIOL EPIDEMI, V2, P60
[7]  
FERSTER LN, 1982, ARK PATOL, V44, P24
[8]   The hamster model of intraperitoneal Burkholderia mallei (glanders) [J].
Fritz, DL ;
Vogel, P ;
Brown, DR ;
Waag, DM .
VETERINARY PATHOLOGY, 1999, 36 (04) :276-291
[9]  
Harley VS, 1998, MICROBIOS, V94, P35
[10]  
Hornick R.B., 1982, INFECT CHILDREN, P910